Concepedia

Paweł Dobrzański

PD

Statistics

Publications

34

Citations

3.2K

H-Index

27

Active since

1982

Affiliations

Bristol-Myers Squibb (United States)(Current)

OncoArendi Therapeutics (Poland)

Medical University of Warsaw

University of Pennsylvania

Postgraduate School of Molecular Medicine

Paweł Dobrzański is an author at Bristol-Myers Squibb (United States) specializing in life sciences, medicine, and pharmacology.

Publications per year

1982–2022

34

Publications

34

RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.

Rolf-Peter Ryseck, Paulina Bull, Mónica Takamiya et al. · Molecular and Cellular Biology · 1992 · 355 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease

Beatrice Hauss‐Wegrzyniak, Paweł Dobrzański, James D. Stoehr et al. · Brain Research · 1998 · 342 citations

Life Sciences, Neurobiology, Neuroscience +14

The MLK Family Mediates c-Jun N-Terminal Kinase Activation in Neuronal Apoptosis

Zhiheng Xu, Anna C. Maroney, Paweł Dobrzański et al. · Molecular and Cellular Biology · 2001 · 267 citations

Life Sciences, Neurobiology, Neuroscience +16

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan et al. · Blood · 2007 · 252 citations · Full text

Life Sciences, Cell Biology, Hematology +12

Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist

Paweł Dobrzański, Kathryn Hunter, Susan Jones‐Bolin et al. · Cancer Research · 2004 · 160 citations

Medicine, Oncology, Pharmacology +13

1–5 of 34